SANGANI2024-10-012025-03-31SANGANI2025-03-31SANGANI2024-03-31SANGANI2024-04-012025-03-31SANGANI2024-10-012025-03-31in-capmkt:OtherExpenses1MemberSANGANI2024-04-012025-03-31in-capmkt:OtherExpenses1MemberSANGANI2024-10-012025-03-31AuditorDomain1iso4217:INRxbrli:pureiso4217:INRxbrli:shares000000SANGANINOTLISTEDINE0OVI01010SANGANI HOSPITALS LIMITEDSMEEquity2024-04-012025-03-312025-05-302025-05-21INRLakhsHalf YearlyYearlySingle segmentHEALTHCARE2025-05-3012:00:002025-05-3023:30:00trueCash Flow IndirectDeclaration of unmodified opinion2024-10-012025-03-31AuditedConsolidated1117690008468000120237000555660000185000213850000424700027035000108418000118190000118190000118190002415000544000295900088600000008860000008860000137770000100.640.64000Notes: <BR> 1.The above results were reviewed and recommended by the Audit Committee, at its meeting held on May 30,2025, for approval by the Board and these results were approved and taken on record at the meeting of the Board of Directors of the Company held on that date. The above result is subjected to Limited Review by the Statutory Auditors of the Company, as required under Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. <BR> <BR> <BR> 2. These results have been prepared in accordance with the recognition and measurement principles laid down in AS-25 "Interim Financials Reporting" presribed under Section 133 of the Companies Act, 2013 read with the relevant Rules issued thereunder and other accounting principles generally accepted in India. <BR> <BR> 3. The figures for the half year ended on 31st March, 2025 are the balancing figures between the audited figures in respect of the full financial year 2024-25 and the half year ended unaudited figures upto 30th September, 2024 <BR> <BR> 4. The Company is engaged in the business of healthcare related services. In the management opinion, this is the only segment and hence there are no separate reportable segment as per AS-17 on Segement Reporting. <BR> <BR> 5. The Compnay has completed its Initial Public Offering ("IPO") of 37,92,000 new Equity Shares of Rs. 10 each at premium of Rs. 30 each per Equity Shares aggregating to Rs. 1516.80 lakhs. Pursuant to the IPO, the Equity Shares of the Company have got listed on NSE Emerge Platform on August 17, 2023. <BR> <BR> 6. The above consolidated financial result include the result of Subsidiary firm; M/s. Ankur Distributors <BR> <BR> 7. The above financial results are available on the website of the company i.e. www.sanganihospitals.com and on the website of emerge platform of National Stock Exchange i.e. www.nseindia.com <BR> <BR> 8.Figures for previous half year/ year have been regrouped wherever necessary to make them comparable. <BR> 2024-04-012025-03-31AuditedConsolidated211852000160660002279180001013330000-351400040167000059550004936000019330100034617000034617000034617000691000017690008679000259380000002593800000259380001377700001001.881.88000other27035000other49360000137770000223087000036085700000293000853000471600000907000647600000101740001017400013130000875000241790003918050001317670000000013176700000027463000015923000001125200029483000018167000001017000023257500039180500005955000000000005955000-3514000-6964000-9125000-3120008911000799000-10205000-425000030367000000691000002345700000234570000000000001091700000000000000-1091700000-1091700000000000-22574000-2257400000-22574000-100340000-10034000191704000181670000AuditedtrueKUMBHAT & COMPANYtrue2026-09-30